Else Nutrition Holdings Inc
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Hamutal Yitzhak
- Full Time Employees
- 12
- Sector
- Health technology
- Industry
- Pharmaceuticals: other
- Address
- 6 Hanechoshet Street Tel Aviv Israel 6971070
- IPO Date
- Sep 26, 2019
- Website
- elsenutrition.com
- Similar Companies
- Business
- Else Nutrition Holdings Inc. (TSX:BABY; OTC:BABYD) is a plant-based nutrition company focused on the research, development, manufacturing, marketing and sale of clean-label, whole-food products for infants, toddlers, children and adults. The company offers plant-based complete nutrition formulas made from almonds, buckwheat and tapioca; baby and toddler snacks; complementary foods; toddler drinks for ages 12-36 months; follow-on formulas; and baby feeding accessories including sterile and non-sterile feeding bottles, teats and disposable nipples. Its products, which exclude dairy, soy, gluten, GMOs, corn syrup, palm oil and artificial ingredients, target consumers seeking alternatives for dietary restrictions, sensitive tummies and plant-based lifestyles, and are distributed through online channels and select retailers in North America, Israel, Australia and New Zealand. Founded in 2012 and headquartered at 6 Hanechoshet Street in Tel Aviv, Israel, with additional offices in Vancouver, British Columbia, Canada, the company employs approximately 13 people and reports sales across vitamins and nutrition products, with 2024 geographic revenue primarily from the United States (CAD 6.17 million), Canada (CAD 937,000) and Israel (CAD 856,000). Recent developments include a November 2025 convertible security funding agreement with Lind Global Fund III LP, managed by The Lind Partners LLC, for gross proceeds of up to US$1.28 million to support production and operations; and a December 2025 five-year renewal of a tender with Israel's largest health fund for nationwide supply of baby feeding accessories to hospitals and maternity wards, securing approximately 7% of 2024 revenue.
Company News
Else Nutrn Hldg (OTCMKTS:BABYF) Stock Short Interest Drops 99.9%
Else Nutrn Hldg (OTCMKTS:BABYF) Sees Significant Growth in Short Interest
Else Nutrition Confirms Trading on a Post-Consolidation Basis
Else Nutrition Announces CSE Listing and Consolidation
Else Nutrition Announces CSE Conditional Approval
Else Nutrition Commends Trump Administration's Expanded Commitment to Bolstering Infant Formulas Regulation in FY2027
Else Nutrition Reports Fiscal Year 2025 Financial Results and Highlights Operational Progress, Strengthened Financial Foundation, and Clear Path Toward Profitability
Else Nutrn (OTCMKTS:BABYF) vs. Medtronic (NYSE:MDT) Financial Survey
Else Nutrition Expected to Benefit from FDA Regulatory Progress on Infant Formula Protein Standards
Else Nutrition Surpasses One Million Cans Sold Since Launch
Else Nutrition Announces Results from Annual General Meeting of Shareholders
Else Nutrition Plans Canadian Market Relaunch in 2026
Else Nutrition Announces Appointment of Natie Zilberberg as Chief Financial Officer
Else Nutrition Achieves Transformative Operational and Financial Progress in 2025
ELSE NUTRITION ANNOUNCES FURTHER EXTENSION OF ANNUAL GENERAL MEETING OF SHAREHOLDERS
Else Nutrition CEO to Present at Investor Summit Virtual on December 9, 2025
Else Nutrition Secures Five-Year Renewal of Israel's Largest Health Fund Tender for Baby Feeding Solutions
Else Nutrition Announces Major Breakthrough: President Trump Signs Pivotal FDA Funding Package that Includes Congressional Directive Streamlining Regulatory Pathway for Non-Dairy, Non-Soy Plant-Based Infant Formula
Else Nutrition Reports Significant Operational Turnaround in Q3 2025 with Gross Margin Expansion and Cost Reduction
Else Nutrition Reschedules 2025 Third Quarter Business Update Conference Call